Sutro Biopharma, Inc 10-K for FY2024
Sutro Biopharma, Inc. (STRO)
10-K
2025-03-13
For: 2024-12-31
View Original
Added on
April 11, 2026
About this 10-K
Sutro Biopharma, Inc filed this 10-K on March 13, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $62.04M
- down 59.6% from $153.73M a year earlier
- Net loss
- $227.46M
- compared with a net loss of $106.79M a year earlier
- Diluted EPS
- -$2.96
- compared with -$1.78 a year earlier